Acetylcholinesterase (AChE) is a key enzyme in termination of fast cholinergic transmission. In brain, acetylcholine (ACh) is produced by cholinergic neurons and released in extracellular space where it is cleaved by AChE anchored by protein PRiMA. Recently, we showed that the lack of AChE in brain of PRiMA knock-out (KO) mouse increased ACh levels 200-300 times. The PRiMA KO mice adapt nearly completely by the reduction of muscarinic receptor (MR) density. Here we investigated changes in MR density, AChE, butyrylcholinesterase (BChE) activity in brain in order to determine developmental period responsible for such adaptation. Brains were studied at embryonal day 18.5 and postnatal days (pd) 0, 9, 30, 120, and 425. We found that the AChE activity in PRiMA KO mice remained very low at all studied ages while in wild type (WT) mice it gradually increased till pd120. BChE activity in WT mice gradually decreased until pd9 and then increased by pd120, it continually decreased in KO mice till pd30 and remained unchanged thereafter. MR number increased in WT mice till pd120 and then became stable. Similarly, MR increased in PRiMA KO mice till pd30 and then remained stable, but the maximal level reached is approximately 50% of WT mice. Therefore, we provide the evidence that adaptive changes in MR happen up to pd30. This is new phenomenon that could contribute to the explanation of survival and nearly unchanged phenotype of PRiMA KO mice.

1st Faculty of Medicine Institute of Physiology Charles University Prague Czech Republic

Zobrazit více v PubMed

Pepeu G, Giovannini MG (2010) Cholinesterase inhibitors and memory. Chemico-Biological Interactions 187: 403–408. PubMed

Guzman MS, De Jaeger X, Raulic S, Souza IA, Li AX, et al. (2011) Elimination of the Vesicular Acetylcholine Transporter in the Striatum Reveals Regulation of Behaviour by Cholinergic-Glutamatergic Co-Transmission. PLoS Biol 9: e1001194. PubMed PMC

Hut RA, Van der Zee EA (2011) The cholinergic system, circadian rhythmicity, and time memory. Behavioural Brain Research 221: 466–480. PubMed

Williams MJ, Adinoff B (2007) The Role of Acetylcholine in Cocaine Addiction. Neuropsychopharmacology 33: 1779–1797. PubMed PMC

Aosaki T, Miura M, Suzuki T, Nishimura K, Masuda M (2010) Acetylcholine–dopamine balance hypothesis in the striatum: An update. Geriatrics & Gerontology International 10: S148–S157. PubMed

Bazalakova MH, Blakely RD (2006) The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. Handb Exp Pharmacol: 525–544. PubMed

Oda Y (1999) Choline acetyltransferase: The structure, distribution and pathologic changes in the central nervous system. Pathology International 49: 921–937. PubMed

Brandon EP, Lin W, D’Amour KA, Pizzo DP, Dominguez B, et al. (2003) Aberrant Patterning of Neuromuscular Synapses in Choline Acetyltransferase-Deficient Mice. The Journal of Neuroscience 23: 539–549. PubMed PMC

de Castro BM, De Jaeger X, Martins-Silva C, Lima RDF, Amaral E, et al. (2009) The Vesicular Acetylcholine Transporter Is Required for Neuromuscular Development and Function. Molecular and Cellular Biology 29: 5238–5250. PubMed PMC

Wess J, Han S-J, Kim S-K, Jacobson KA, Li JH (2008) Conformational changes involved in G-protein-coupled-receptor activation. Trends in Pharmacological Sciences 29: 616–625. PubMed PMC

Le Novère N, Corringer P-J, Changeux J-P (2002) The diversity of subunit composition in nAChRs: Evolutionary origins, physiologic and pharmacologic consequences. Journal of Neurobiology 53: 447–456. PubMed

Marks M, Laverty D, Whiteaker P, Salminen O, Grady S, et al. (2010) John Daly’s Compound, Epibatidine, Facilitates Identification of Nicotinic Receptor Subtypes. Journal of Molecular Neuroscience 40: 96–104. PubMed PMC

Massoulié J, Perrier N, Noureddine H, Liang D, Bon S (2008) Old and new questions about cholinesterases. Chemico-Biological Interactions 175: 30–44. PubMed

Perrier AL, Massoulie J, Krejci E (2002) PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33: 275–285. PubMed

Dobbertin A, Hrabovska A, Dembele K, Camp S, Taylor P, et al. (2009) Targeting of Acetylcholinesterase in Neurons In Vivo: A Dual Processing Function for the Proline-Rich Membrane Anchor Subunit and the Attachment Domain on the Catalytic Subunit. The Journal of Neuroscience 29: 4519–4530. PubMed PMC

Abreu-Villaça Y, Filgueiras CC, Manhães AC (2011) Developmental aspects of the cholinergic system. Behavioural Brain Research 221: 367–378. PubMed

Holler T, Berse B, Cermak JM, Diebler M-F, Blusztajn JK (1996) Differences in the developmental expression of the vesicular acetylcholine transporter and choline acetyltransferase in the rat brain. Neuroscience Letters 212: 107–110. PubMed

Aznavour N, Watkins KC, Descarries L (2005) Postnatal development of the cholinergic innervation in the dorsal hippocampus of rat: Quantitative light and electron microscopic immunocytochemical study. The Journal of Comparative Neurology 486: 61–75. PubMed

Mechawar N, Descarries L (2001) The cholinergic innervation develops early and rapidly in the rat cerebral cortex: a quantitative immunocytochemical study. Neuroscience 108: 555–567. PubMed

Moreno RD, Campos FO, Dajas F, Inestrosa NC (1998) Developmental regulation of mouse brain monomeric acetylcholinesterase. Int J Dev Neurosci 16: 123–134. PubMed

Sawyer TW, Weiss MT (1993) Parallel development of acetylcholinesterase in vivo and in primary neuron surface culture. Brain Res Dev Brain Res 71: 147–149. PubMed

Xie HQ, Leung KW, Chen VP, Chan GKL, Xu SL, et al. (2010) PRiMA directs a restricted localization of tetrameric AChE at synapses. Chemico-Biological Interactions 187: 78–83. PubMed

Svedberg MM, Svensson A-L, Bednar I, Nordberg A (2003) Neuronal nicotinic and muscarinic receptor subtypes at different ages of transgenic mice overexpressing human acetylcholinesterase. Neuroscience Letters 340: 148–152. PubMed

Lammerding-Koppel M, Greiner-Schroder A, Drews U (1995) Muscarinic receptors in the prenatal mouse embryo. Comparison of M35-immunohistochemistry with [3H]quinuclidinyl benzylate autoradiography. Histochem Cell Biol 103: 301–310. PubMed

Fiedler EP, Marks MJ, Collins AC (1987) Postnatal development of cholinergic enzymes and receptors in mouse brain. J Neurochem 49: 983–990. PubMed

Bernard V, Decossas M, Liste I, Bloch B (2006) Intraneuronal trafficking of G-protein-coupled receptors in vivo. Trends Neurosci 29: 140–147. PubMed

Farar V, Mohr F, Legrand M, Lamotte d’Incamps B, Cendelin J, et al. (2012) Near complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase. Journal of Neurochemistry 122: 1065–1080. PubMed

Zheng Q, Olivier K, Won YK, Pope CN (2000) Comparative Cholinergic Neurotoxicity of Oral Chlorpyrifos Exposures in Preweanling and Adult Rats. Toxicological Sciences 55: 124–132. PubMed

Bajgar J, Fusek J, Kassa J, Jun D, Kuca K, et al. (2008) An attempt to assess functionally minimal acetylcholinesterase activity necessary for survival of rats intoxicated with nerve agents. Chemico-Biological Interactions 175: 281–285. PubMed

Maxwell D, Brecht K, Koplovitz I, Sweeney R (2006) Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds? Archives of Toxicology 80: 756–760. PubMed

Myslivecek J, Duysen EG, Lockridge O (2007) Adaptation to excess acetylcholine by downregulation of adrenoceptors and muscarinic receptors in lungs of acetylcholinesterase knockout mice. Naunyn Schmiedebergs Arch Pharmacol 376: 83–92. PubMed

Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95. PubMed

Mrvova K, Obzerova L, Girard E, Krejci E, Hrabovska A (2012) Monoclonal antibodies to mouse butyrylcholinesterase. Chemico-Biological Interactions 203: 348–353. PubMed

Xie W, Stribley JA, Chatonnet A, Wilder PJ, Rizzino A, et al. (2000) Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J Pharmacol Exp Ther 293: 896–902. PubMed

Lassiter TL, Barone Jr S, Padilla S (1998) Ontogenetic differences in the regional and cellular acetylcholinesterase and butyrylcholinesterase activity in the rat brain. Developmental Brain Research 105: 109–123. PubMed

Geula C, Nagykery N (2007) Butyrylcholinesterase activity in the rat forebrain and upper brainstem: Postnatal development and adult distribution. Experimental Neurology 204: 640–657. PubMed

Bullock R, Lane R (2007) Executive dyscontrol in dementia, with emphasis on subcortical pathology and the role of butyrylcholinesterase. Curr Alzheimer Res 4: 277–293. PubMed

Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, et al. (2002) Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110: 627–639. PubMed

Alexander S, Mathie A, Peters J (2011) Guide to Receptors and Channels (GRAC), 5th edition. British Journal of Pharmacology 164: 1–324. PubMed PMC

Michel MC, Wieland T, Tsujimoto G (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379: 385–388 doi: 310.1007/s00210-00009-00395-y. Epub 02009 Jan 00227 PubMed

Jositsch G, Papadakis T, Haberberger R, Wolff M, Wess J, et al. (2009) Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn-Schmiedeberg’s Archives of Pharmacology 379: 389–395. PubMed PMC

Yamada N, Sasaki S, Ishii H, Sato J, Kanno T, et al... (2011) Dark cell change of the cerebellar Purkinje cells induced by terbutaline under transient disruption of the blood-brain barrier in adult rats: morphological evaluation. Journal of Applied Toxicology. PubMed

Massoulie J (2002) The origin of the molecular diversity and functional anchoring of cholinesterases. Neurosignals 11: 130–143. PubMed